NewAmsterdam Pharma Company N.V. (NAMS)

NASDAQ: NAMS · Real-Time Price · USD

24.12

-0.07 (-0.29%)

At close: Sep 15, 2025, 4:00 PM EDT

24.12

0.00 (0.00%)

After-hours: Sep 15, 2025, 4:39 PM EDT

NAMS Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	64.01	45.56	14.09	102.69	-	-
Revenue Growth (YoY)	762.15%	223.37%	-86.28%	-	-	-
Gross Profit	64.01	45.56	14.09	102.69	-	-
Selling, General & Admin	93.93	70.45	37.63	19.51	6	1.69
Research & Development	142.86	151.41	159.42	86.74	28.97	4.95
Operating Expenses	236.8	221.85	197.06	106.25	34.98	6.64
Operating Income	-172.79	-176.29	-182.97	-3.56	-34.98	-6.64
Interest Expense	-	-	-	-0.29	-0.41	-0.42
Interest & Investment Income	23.33	16.88	11.28	-	-	-
Currency Exchange Gain (Loss)	9.73	-6.6	5.06	-9.75	1.71	0.03
Other Non Operating Income (Expenses)	1.42	-38.58	-10.02	-8.34	-7.22	-
EBT Excluding Unusual Items	-138.3	-204.59	-176.64	-21.93	-40.9	-7.03
Other Unusual Items	-27.41	-37.01	-0.27	-0.71	-0.88	-
Pretax Income	-165.72	-241.6	-176.91	-22.63	-41.79	-7.03
Income Tax Expense	-0	-0	0.03	-	-	-
Net Income	-165.72	-241.6	-176.94	-22.63	-41.79	-7.03
Net Income to Common	-165.72	-241.6	-176.94	-22.63	-41.79	-7.03
Shares Outstanding (Basic)	107	94	82	19	11	5
Shares Outstanding (Diluted)	107	94	82	19	11	5
Shares Change (YoY)	23.19%	14.84%	333.20%	72.75%	119.58%	-
EPS (Basic)	-1.55	-2.56	-2.15	-1.19	-3.81	-1.41
EPS (Diluted)	-1.55	-2.56	-2.15	-1.19	-3.81	-1.41
Free Cash Flow	-124.3	-159.24	-141.24	10.44	-29.54	-7.32
Free Cash Flow Per Share	-1.16	-1.69	-1.72	0.55	-2.69	-1.46
Gross Margin	100.00%	100.00%	100.00%	100.00%	-	-
Operating Margin	-269.96%	-386.91%	-1298.56%	-3.46%	-	-
Profit Margin	-258.90%	-530.25%	-1255.76%	-22.04%	-	-
Free Cash Flow Margin	-194.21%	-349.49%	-1002.43%	10.17%	-	-
EBITDA	-172.62	-176.18	-182.92	-3.55	-34.97	-6.64
EBITDA Margin	-269.69%	-	-	-3.45%	-	-
D&A For EBITDA	0.18	0.11	0.05	0.01	0.01	0
EBIT	-172.79	-176.29	-182.97	-3.56	-34.98	-6.64
EBIT Margin	-269.96%	-	-	-3.46%	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q